Addex Therapeutics Ltd. (ADXN)
4.15
+0.25
(+6.41%)
USD |
NASDAQ |
Aug 26, 12:06
Addex Therapeutics Gross Profit Margin (Quarterly) : -27.55% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -27.55% |
| December 31, 2025 | 86.87% |
| September 30, 2025 | 95.65% |
| June 30, 2025 | 94.09% |
| March 31, 2025 | 0.00% |
| December 31, 2024 | -1.49K% |
| September 30, 2024 | 8.17% |
| June 30, 2024 | 2.51% |
| March 31, 2024 | 98.73% |
| December 31, 2023 | 0.00% |
| September 30, 2023 | 0.00% |
| June 30, 2023 | 0.00% |
| March 31, 2023 | 0.00% |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2007 | |
| June 30, 2007 | 0.00% |
| March 31, 2007 | -3.68K% |
| December 31, 2006 | |
| June 30, 2006 | 0.00% |
| March 31, 2006 | -344.9% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Novartis AG | 74.47% |
| Roche Holding AG | -- |
| Oculis Holding AG | -- |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -122.5% |
| Return on Assets | -98.99% |
| Return on Invested Capital | -121.4% |
| Profit Margin (Quarterly) | -22.29K% |
| Operating Margin (Quarterly) | -6.25K% |
| Return on Net Operating Assets | -2.66K% |